MENU
March 16-17 8:00am EDT

MilliporeSigma Virtual IVD Conference

Join the two-Day Virtual IVD Conference on advancing immunoassay technology and performance

Making an in vitro diagnostic assay has never been easy. Now with the global lab and supply chain and disruptions caused by the COVID pandemic, the development and manufacture of IVDs faces further challenges.

Fortunately, the successful commercialization of your assay in these turbulent times and beyond can benefit from some important, often overlooked considerations in design and planning.


Attend the virtual, two-day IVD conference where international technical experts and scientists will address key aspects of IVD immunoassay (CLIA, immunoturbidimetry, qualitative and quantitative lateral flow, etc.) development and performance, including:

  • design considerations
  • critical raw materials selection & sourcing
  • analytical controls
  • magnetic separation technology
  • risk mitigation
  • new IVD regulations

 

Join us to learn about current and future IVD technologies and market trends, both now, and post-COVID from industry leaders, while taking advantage of networking opportunities and a supplier exhibition. We look forward to staying connected with you virtually!
 

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.


Speakers

Show Resources
You May Also Like
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Thirteen years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2022 Clinical Diagnostics and Research Virtual Event will again bring together clinic...
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 8th Annu...
MAR 23, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAR 23, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce the 5th Annual 2021 Cannabis Sciences Virtual Event . LabRoots will host the event on March 23, 2022. The Cannabis Sciences planning committee will be plannin...
APR 19, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
APR 19, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to announce our 10th Annual Genetics Virtual Week held on April 19-21, 2022! Genetics Virtual Week 2022 will offer a multi-day content-rich program combining stellar expe...
Agenda
  • Exhibit Hall
    MAR 17, 2021 12:00 PM EDT
    Exhibit Hall

  • MAR 17, 2021 11:30 AM EDT
    Live Q&A with Elena Pérez and Patrick Ducoroy
    Elena Rivas Pérez, Patrick Ducoroy, Matthew Coussens, Ph.D.
    Elena C. Rivas Pérez
    CEO at A4Cell and Vice President of Spanish Biotech Com...
    Patrick Ducoroy
    Chief Executive Officer, Biomaneo
    Matthew Coussens, Ph.D.
    Product Training Manager, Diagnostic Solutions, Millipo...
  • The complexity of IVD Certification in the Case of Disruptive Technology Combining Kit + Instrument + Software
    MAR 17, 2021 11:00 AM EDT
    The complexity of IVD Certification in the Case of Disruptive Technology Combining Kit + Instrument + Software
    Patrick Ducoroy
    Chief Executive Officer, Biomaneo
  • SPAchip Technology, a Window Inside Living Cells
    MAR 17, 2021 10:30 AM EDT
    SPAchip Technology, a Window Inside Living Cells
    Elena Rivas Pérez
    CEO at A4Cell and Vice President of Spanish Biotech Companies Association (ASEBIO)
  • MAR 17, 2021 10:00 AM EDT
    Live Q&A with Dr. Huang and Dr. León
    Dr. Charlie Huang, Dr. Virginia León, Matthew Coussens, Ph.D.
    Dr. Charlie Huang
    Head of Diagnostics & Life Science, AnteoTech Ltd
    Dr. Virginia León
    Lateral Flow Product Specialist, OPERON, S.A.
    Matthew Coussens, Ph.D.
    Product Training Manager, Diagnostic Solutions, Millipo...
  • The True Cost of a 1 USD per Test: To Automate or not Automate the Production
    MAR 17, 2021 9:30 AM EDT
    The True Cost of a 1 USD per Test: To Automate or not Automate the Production
    Dr. Virginia León
    Lateral Flow Product Specialist, OPERON, S.A.
  • Applying AnteoBind™ Activated Estapor® Europium Particles for Development of Quantitative Fluorescent Lateral Flow Assays
    MAR 17, 2021 9:00 AM EDT
    Applying AnteoBind™ Activated Estapor® Europium Particles for Development of Quantitative Fluorescent Lateral Flow Assays
    Dr. Charlie Huang
    Head of Diagnostics & Life Science, AnteoTech Ltd
  • Exhibit Hall
    MAR 17, 2021 8:00 AM EDT
    Exhibit Hall

  • Exhibit Hall
    MAR 16, 2021 12:00 PM EDT
    Exhibit Hall

  • MAR 16, 2021 11:30 AM EDT
    Live Q&A with Dr. Delshadi and Dr. Schumacher
    Dr. Sarah Delshadi, Dr. Thomas Schumacher, Matthew Coussens, Ph.D.
    Dr. Sarah Delshadi
    R&D and R&A Director, Co-Founder, MagIA Diagnostics
    Dr. Thomas Schumacher
    Chief Scientific Officer Institut Virion\Serion GmbH
    Matthew Coussens, Ph.D.
    Product Training Manager, Diagnostic Solutions, Millipo...
  • High Performance Rubella IgM Assay on Superparamagnetic Beads with a Novel Recombinant Rubella Antigen
    MAR 16, 2021 11:00 AM EDT
    High Performance Rubella IgM Assay on Superparamagnetic Beads with a Novel Recombinant Rubella Antigen
    Dr. Thomas Schumacher
    Chief Scientific Officer Institut Virion\Serion GmbH
  • New POC System Based on Small Magnetic Microspheres and Offering Great Analytical Performance
    MAR 16, 2021 10:30 AM EDT
    New POC System Based on Small Magnetic Microspheres and Offering Great Analytical Performance
    Dr. Sarah Delshadi
    R&D and R&A Director, Co-Founder, MagIA Diagnostics
  • MAR 16, 2021 10:00 AM EDT
    Live Q&A with Dr. Martinez & Dr. Lermo
    Dr. Lluis Martinez, Dr. Anabel Lermo, Matthew Coussens, Ph.D.
    Dr. Lluis M. Martinez
    Chief Scientific Officer and Founder, Sepmag
    Dr. Anabel Lermo
    Senior Researcher, Pragmatic Diagnostics
    Matthew Coussens, Ph.D.
    Product Training Manager, Diagnostic Solutions, Millipo...
  • Estapor® Magnetic Microspheres for Development of Chemilumescent Immunoassays
    MAR 16, 2021 9:30 AM EDT
    Estapor® Magnetic Microspheres for Development of Chemilumescent Immunoassays
    Dr. Anabel Lermo
    Senior Researcher, Pragmatic Diagnostics
  • From R&D to Large Volume Production: Keys for a Smooth Biomagnetic Separation Process Transfer
    MAR 16, 2021 9:00 AM EDT
    From R&D to Large Volume Production: Keys for a Smooth Biomagnetic Separation Process Transfer
    Dr. Lluis Martinez
    Chief Scientific Officer and Founder, Sepmag
  • Exhibit Hall
    MAR 16, 2021 8:00 AM EDT
    Exhibit Hall

Speakers

  • Matthew Coussens, Ph.D.
    Product Training Manager, Diagnostic Solutions, MilliporeSigma
    Biography

      Matt is currently the product training manager of Diagnostics Solutions for MilliporeSigma. His primary responsibility is driving technology and product education to MilliporeSigma's global customer base.  Prior to this, he held a post-doctoral fellowship at Washington University in St Louis, MO, and earned a Ph.D. in Cell and Molecular Biology from the University of Hawaii at Manoa where his research focused on embryonic development and stem cell biology.

    • Dr. Sarah Delshadi
      R&D and R&A Director, Co-Founder, MagIA Diagnostics
      Biography

        Since 2018
        R&D and R&A director, co-founder of MagIA diagnostics
         
        2014 - 2017
        PhD student in Biotechnology
        G2Elab - IAB (Grenoble)
        Fast innovative immunoassays exploiting superparamagnetic nanoparticles and micro-magnets

        2013
        Institut Pasteur de Madagascar
        Development of molecular biologic tools for detection, identification and genotype of opportunistic parasites (Microsporidia) in diarrheic children in Madagascar

        2012
        LMGP - G2Elab (Grenoble)
        Development of a Biologic Magnetic Micro-Electro- Mechanical System involved in the immunodiagnostic of HCV antigen

        2011
        CEA (Grenoble)
        Production and purification of proteins BMP9 and BMP10 on HEK 293

      • Patrick Ducoroy
        Chief Executive Officer, Biomaneo
        Biography

          Patrick DUCOROY received his PhD from Dijon, Bourgogne University (2002). He was a research assistant and head of Proteomics Studies for the Department of Exploratory Biology of Laboratoires FOURNIER, Solvay Pharmaceuticals Company, Dijon (2002-2004). Patrick DUCOROY has managed the biotechnological platform “Clinical & Innovation Proteomic Platform (CLIPP)” from Bourgogne/Franche-Comté University (2005-2015). Patrick DUCOROY's research was focused on the combining knowledge and know-how in the fields of proteomics, mass spectrometry, chemistry, nano engineering, biostatistics and bioinformatics to respond to the problematics of biologists and to develop new approaches and/or original tools for the analysis of proteomics. 


          In 2016, Patrick DUCOROY founded BIOMANEO company with Valérie GEOFFROY. He pursues his research and development on the set up of methodologies of high throughput screening including Proteomics analytical tools combined with IT solutions adapted to help the interpretation of results. Patrick DUCOROY's research is focused on the setup of plug and play analytical solutions since the samples until the interpretation of results, including technologies such as MALDI, LC-MS/MS, RAMAN….Research Patrick DUCOROY's is focused on the hemoglobinopathies and initiated the adaptation of methods (nano biosensors, Mass spectrometry and bioinformatics tools) for the screening of other pathologies such as cystic fibrosis, cancer (Liver, Bladder), neurodegenerative disease (Alzheimer), infection (COVID19)…
           

        • Dr. Charlie Huang
          Head of Diagnostics & Life Science, AnteoTech Ltd
          Biography

            Dr Charlie Huang has more than 20 years of experience in the multi-discipline environment. He is a full spectrum industrial executive with experiences ranging from concept generation, upstream research, product design, development, manufacturing to commercialisation.

            He has demonstrated scientific expertise in the fields of life sciences, in vitro diagnostics, biotechnology and nanotechnology. He also has significant commercial expertise in business development, commercial strategy, project & team management, technology analysis & transfer, licensing and intellectual proprieties.

            Prior to joining Anteo, he has held senior management roles in several public listed healthcare and IVD companies including Panbio Ltd, Alere, Cellestis Ltd and QIAGEN. He is working with the Anteo team to develop strategies, patents, products and services for industrial and life science applications and commercialisation.

            He holds a BSc in Life Science and an MSc in Molecular Engineering from NCHU. He obtained his PhD in Biochemistry and Molecular Biology from the University of Queensland in 2000. He has published scientific papers with strong impact factors and is co-inventor of many granted patents in the fields of novel diagnostics, medical devices, metal complex applications and energy.

          • Dr. Virginia León
            Lateral Flow Product Specialist, OPERON, S.A.
            Biography

              Virginia obtained a Science Bachelor's degree in Biochemistry and a PhD in Science from Zaragoza University in Spain. 


              She joined OPERON S.A. as Project Manager at the Lateral Flow (LF) R&D Department in 2010. She was in charge of the design and development of rapid tests. 


              Since 2015, she works as LF Product Specialist at the Sales & Marketing Department designing product specifications, providing technical support and managing contract manufacturing accounts. 

            • Dr. Anabel Lermo
              Senior Researcher, Pragmatic Diagnostics
              Biography

                Dr. Anabel Lermo is a Research Scientist with demonstrated experience in the field of In-Vitro Diagnostic (IVD), skilled in the design of complex platforms for immunoassay sensing. 


                She holds a PhD in Chemistry (Honoured) from the UAB of Barcelona. Her thesis was focused on the design of biomolecular approaches in electrochemical biosensing devices for alimentary field. She worked as a postdoctoral fellow at Analytical Chemistry Division UAB as a leading researcher of investigation projects for immunoassay development applied to biosensor design in the alimentary and clinical fields. Then, she joined Biokit (a company of the Werfen group) for 7 years, developing chemiluminescent immunoassays for automated platforms in the field of infectious diseases. Her activities were mainly focused on the optimization of key component formulation and analyser assay parameters, transferring the reagent to production, generating all the documentation required for verification, validation and registration of the product in various regulatory agencies (CE, Shonin and CFDA). 


                She currently works at Pragmatic Diagnostics developing new assays where immunometric technologies are integrated with appropriate analytical platforms in a streamlined and efficient manner for IVD industry.

              • Dr. Lluis M. Martinez
                Chief Scientific Officer and Founder, Sepmag
                Biography

                  Founder of SEPMAG, Lluis holds a Ph.D. in Magnetic Materials from the UAB. He has conducted research in German and Spanish academic institutions. Having worked in companies in Ireland, the USA, and Spain, he cumulates more than 20 years of experience, applying magnetic materials and sensors to industrial products and processes. He has filed several international patents on the field and co-authored more than 30 scientific papers, most of them related to the movement of magnetic particles. 

                • Elena C. Rivas Pérez
                  CEO at A4Cell and Vice President of Spanish Biotech Companies Association (ASEBIO)
                  Biography

                    Vicepresident of Spanish Biotech Companies Association (ASEBIO)


                    Chief Executive Officer | ARRAYS FOR CELL NANODEVICESSL | MADRID     
                    September 2019 – Today
                    General management of the company 
                    Scaleup of disruptive technology from CSIC licensed by A4Cell  
                    Create company, brand, product and applications from the initial project
                    Sectors: High Content Screening market and cell therapy

                    Business Development Manager | NANOIMMUNOTECH SL | MADRID     
                    December 2016 – August 2019
                    Leadership and management of the sales and marketing team 
                    Starting of the international marketing strategy for HEATSENS Technology
                    Search for partners who want to launch Heatsens in their developments
                    Sectors: IVD Diagnostic, research, food safety and animal health

                    Brand Manager | BIOMEDAL, SL | MADRID
                    December 2008 – December 2016
                    Leadership and management of the sales and marketing team 
                    Management of the food safety business 
                    Designing of the strategic business for gliadin detection test 
                    Searching of the network distributors around the world.
                    Launching of the first test to detect toxic peptide in urine samples for coeliac patients.
                    Spanish product manager of Bioneer Inc.

                    Product Manager | Bonsai Technologies Group, SL | MADRID
                    July 2006 – November 2008
                    Product manager for Spanish and Portuguese market of three big international suppliers (BIOHIT, BIORON and AXYGEN) 

                    Product Manager | INGENASA, SA | MADRID
                    September 2001- June 2006
                    Manager of the food safety product line as a strategic business 
                    Leadership of the sales team and dealers.

                  • Dr. Thomas Schumacher
                    Chief Scientific Officer Institut Virion\Serion GmbH
                    Biography

                      Since November 2018 Chief Scientific Officer (CSO)
                      - responsible for the development of IVD products (diagnostic tests) and non-IVD products (SERION Immunologics)

                      Since November 2013 Director of SERION Immunologics
                      - responsible for the newly formed business unit SERION Immunologics focussing on the development and sales of critical raw materials like antigens, antibodies, beads and reagents for infectious serology

                      2012 - 2018 Senior manager antigen production and research & development

                      2008 - 2011 Department head antigen production

                      2007 - 2008 Group leader at Siegfried-Biologics GmbH, Berlin, Germany

                      2006 - 2007 Research Scientist at responsif GmbH, Erlangen, Germany

                      2005 - 2006 PostDoc at the RWTH, Aachen, Germany

                      2005 PhD at the RWTH Aachen, Germany, in the field of chemo-enzymatic synthesis of novel erythromycin antibiotics

                    Help

                    General Labroots Questions

                    email support@labroots.com  

                    Virtual Events and Webinars

                    Supported Configurations

                    • Operating System Internet Explorer Firefox Chrome Safari
                      Vista IE8+ FF10+ Chrome15+
                      Windows 7 IE8+ FF10+ Chrome15+
                      Windows 8 IE10 FF10+ Chrome15+
                      Mac OS X   FF10+ Chrome15+ Safari5.1+
                    • Cookie settings: session cookies enabled
                    • Browser configuration must have JavaScript enabled
                    • Adobe Flash player 10.2 or later

                    To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                    Internet Connection

                    • A minimum of 100Kbps is recommended for audio-only events
                    • A minimum of 300Kbps is recommended for speaker on-video events

                    Computer Equipment

                    • Screen Resolution: Minimum 1024x768
                    • Video Card: 65,000 colors minimum
                    • Sound card and speakers (or headphones) for hearing webcast in full format
                    • Audio Card: 16-bit minimum
                    • RAM: 512MB of free RAM

                    Firewall Protocol

                    • HTTP on port 80 or HTTPS on port 443
                    • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                    • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                    Work-At-Home Attendees

                    • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                    For A Seamless Experience

                    When using a mobile device, FREE Mobile Apps are available:

                    - For viewing Webinars:

                    - For viewing Virtual Events

                    Attendee Guide

                    • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                    Virtual Event and Webinar Support:

                    Continuing Education (CME/CE) Support

                    Loading Comments...
                    Show Resources
                    Attendees
                    • See more